Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Angelina, Novak"'
Publikováno v:
Hematology (Amsterdam, Netherlands). 3(1)
Familial juvenile myeloid disorders are uncommon, but better understanding of their basis may lead to crucial advances in the study of leukemogenesis. We report a family with three siblings who died of myelodysplasia and/or acute myeloid leukemia at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d15d51d83ed797e4e1b276444c84e1b
https://pubmed.ncbi.nlm.nih.gov/27416281
https://pubmed.ncbi.nlm.nih.gov/27416281
Autor:
Milica Colovic, Rolović Z, Bosković D, Djordjević, Angelina Novak, Dragomir Marisavljevic, Panitić M, Lazarević
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 132, Iss 1-2, Pp 10-13 (2004)
Cytogenetic analysis has proven to be a mandatory part of the diagnosis of myelodysplastic syndromes (MDS) as well as a major indicator for predicting clinical course and outcome. Aside from the 5q-syndrome, no specific clinico-cytogenetic entity has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f150634fde78675b167e8bfd7f015da6
http://www.doiserbia.nb.rs/img/doi/0370-8179/2004/0370-81790402010M.pdf
http://www.doiserbia.nb.rs/img/doi/0370-8179/2004/0370-81790402010M.pdf
Autor:
Ivo Elezovic, Angelina Novak, Dragomir Marisavljevic, Milica Colovic, Ana Vidovic, Vesna Djordjevic, Milena Pantić
Publikováno v:
Medical Oncology. 17:307-313
Patients with acute promyelocytic leukemia (APL) show other chromosome aberrations in addition to t(15;17) but their influence on the clinical outcome is still unclear. We have cytogeneticaly analyzed 43 APL patients with t(15;17)(q22;q21), treated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede2dee97c3bc67e6afa5c2ebb2b9ca2
https://doi.org/10.1007/bf02782196
https://doi.org/10.1007/bf02782196
Publikováno v:
Scopus-Elsevier
We describe here a 72-year-old female patient with an acute megakaryoblastic leukaemia (M7 by FAB Classification) and systemic lupus erythematosus (SLE). The patient had not been pretreated with immunosuppressive therapy, which is potentially leukaem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10ee5086d7cbd1b63bf54148daa1c5b2
https://doi.org/10.1007/bf02990942
https://doi.org/10.1007/bf02990942
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 134, Iss 9-10, Pp 404-407 (2006)
Introduction: Rearrangements of any single chromosome in human karyotype have been reported in patients with pMDS. Objective: To examine the role of aberrations of chromosome 8 in pathogenesis, clinical presentation and progression of myelodysplastic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fce011e136c2cefdb52bb012b4555b3
https://pubmed.ncbi.nlm.nih.gov/17252907
https://pubmed.ncbi.nlm.nih.gov/17252907
Publikováno v:
Medical oncology (Northwood, London, England). 22(4)
Reports on spontaneous remissions in patients with primary myelodysplastic syndromes (MDS) occasionally appear in the literature. We report five adult patients with spontaneous remission of MDS, achieved without cytotoxic or any other treatment. Thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2983afe3874dad3b52f041704673c6
https://pubmed.ncbi.nlm.nih.gov/16260859
https://pubmed.ncbi.nlm.nih.gov/16260859
Autor:
Dragomir, Marisavljević, Zoran, Rolović, Milena, Panitić, Angelina, Novak, Vesna, Djordjević, Vladimir, Lazarević, Darinka, Bosković, Milica, Colović
Publikováno v:
Srpski arhiv za celokupno lekarstvo. 132(1-2)
Cytogenetic analysis has proven to be a mandatory part of the diagnosis of myelodysplastic syndromes (MDS) as well as a major indicator for predicting clinical course and outcome. Aside from the 5q-syndrome, no specific clinico-cytogenetic entity has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::094b9d5739cf31f809b5147425a4a0db
https://pubmed.ncbi.nlm.nih.gov/15227958
https://pubmed.ncbi.nlm.nih.gov/15227958
Publikováno v:
European Journal of Haematology. 57:188-189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8359f04f21c2d7eb75802287fcb8df95
https://doi.org/10.1111/j.1600-0609.1996.tb01361.x
https://doi.org/10.1111/j.1600-0609.1996.tb01361.x
Publikováno v:
European Journal of Haematology. 49:156-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0327b24a5c27d88718b0b7371d8e1a02
https://doi.org/10.1111/j.1600-0609.1992.tb00924.x
https://doi.org/10.1111/j.1600-0609.1992.tb00924.x
Autor:
Milica Colovic, Dragan Babić, Ivo Elezovic, Jelena Bila, Gradimir Jankovic, Angelina Novak, Ana Vidovic
Publikováno v:
Medical oncology (Northwood, London, England). 14(2)
Between February 1992 and November 1996 we treated 30 newly diagnosed acute promyelocytic leukaemia (APL) patients either with oral all-trans-retinoic acid (ATRA) alone (45 mg m-2) or with a simultaneous combination of ATRA (45 mg m-2), daunorubicin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244eec91665a514df3d19d5beccf4b03
https://pubmed.ncbi.nlm.nih.gov/9330265
https://pubmed.ncbi.nlm.nih.gov/9330265